We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.92%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$6.75B
AUM Growth
+$963M
(+17%)
Cap. Flow
+$702M
Cap. Flow
% of AUM
10.4%
Top 10 Holdings %
Top 10 Hldgs %
4.5%
Holding
2,736
New
363
Increased
1,147
Reduced
950
Closed
272
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$38.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$31M |
| 3 |
Linde
LIN
|
+$30.2M |
| 4 |
Nike
NKE
|
+$27.1M |
| 5 |
EOG Resources
EOG
|
+$26.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$35.3M |
| 2 |
Home Depot
HD
|
+$29.9M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$26.7M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$26M |
| 5 |
Lockheed Martin
LMT
|
+$25.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.68% |
| 2 | Consumer Discretionary | 15.21% |
| 3 | Industrials | 13.29% |
| 4 | Financials | 13.24% |
| 5 | Healthcare | 12.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLXN
2176
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $169K | ﹤0.01% |
16,278
-47,097
| -74% | -$577K |
|
|
DSKE
2177
DELISTED
Daseke, Inc. Common Stock
DSKE
| $168K | ﹤0.01% |
+31,340
| New | +$161K |
|
2178
Atara Biotherapeutics
ATRA
$78M
| $167K | ﹤0.01% |
517
+260
| +101% | +$88.5K |
|
|
TIGR
2179
UP Fintech Holding
TIGR
$877M
| $167K | ﹤0.01% |
+35,200
| New | +$191K |
|
2180
IDEAYA Biosciences
IDYA
$3.54B
| $166K | ﹤0.01% |
13,216
+8,482
| +179% | +$105K |
|
2181
Hanmi Financial
HAFC
$940M
| $165K | ﹤0.01% |
20,047
+5,210
| +35% | +$48.2K |
|
2182
MasterCraft Boat Holdings
MCFT
$583M
| $165K | ﹤0.01% |
+9,433
| New | +$189K |
|
|
RC
2183
Ready Capital
RC
$333M
| $163K | ﹤0.01% |
14,516
-32,468
| -69% | -$309K |
|
2184
Sphere Entertainment
SPHR
$5.83B
| $163K | ﹤0.01% |
2,374
-699
| -23% | -$50.4K |
|
2185
Ardelyx
ARDX
$997M
| $162K | ﹤0.01% |
+30,854
| New | +$185K |
|
2186
Golub Capital BDC
GBDC
$3.41B
| $162K | ﹤0.01% |
12,206
-8,816
| -42% | -$110K |
|
2187
James River Group Holdings
JRVR
$209M
| $162K | ﹤0.01% |
+3,630
| New | +$169K |
|
|
ETNB
2188
DELISTED
89bio
ETNB
| $161K | ﹤0.01% |
6,280
+4,707
| +299% | +$149K |
|
|
SAFE
2189
Safehold
SAFE
$1.09B
| $161K | ﹤0.01% |
2,793
+460
| +20% | +$27.2K |
|
2190
Adaptive Biotechnologies
ADPT
$4.05B
| $160K | ﹤0.01% |
3,283
+83
| +3% | +$3.49K |
|
2191
CytomX Therapeutics
CTMX
$750M
| $160K | ﹤0.01% |
24,044
+17,759
| +283% | +$132K |
|
|
AGRX
2192
DELISTED
Agile Therapeutics
AGRX
| $160K | ﹤0.01% |
26
-6
| -19% | -$34.4K |
|
2193
Invesco Mortgage Capital
IVR
$795M
| $159K | ﹤0.01% |
5,869
-1,907
| -25% | -$58.8K |
|
|
MYOV
2194
DELISTED
Myovant Sciences Ltd.
MYOV
| $159K | ﹤0.01% |
11,336
-9,321
| -45% | -$173K |
|
2195
AnaptysBio
ANAB
$1.64B
| $158K | ﹤0.01% |
10,735
-20,358
| -65% | -$367K |
|
|
WPX
2196
DELISTED
WPX Energy, Inc.
WPX
| $157K | ﹤0.01% |
+32,042
| New | +$177K |
|
2197
SunCoke Energy
SXC
$799M
| $154K | ﹤0.01% |
45,066
-205,504
| -82% | -$670K |
|
2198
NIO
NIO
$12.1B
| $153K | ﹤0.01% |
7,225
-740,533
| -99% | -$11.4M |
|
2199
Viking Therapeutics
VKTX
$4.01B
| $153K | ﹤0.01% |
26,247
-1,202
| -4% | -$8.28K |
|
2200
Alphatec Holdings
ATEC
$1.46B
| $152K | ﹤0.01% |
+22,911
| New | +$129K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q3 2020 Portfolio in Review
As of Q3 2020, Cubist Systematic Strategies held 2,736 positions worth $6.75B, up 17% from $5.79B the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.
Cubist Systematic Strategies deployed $702M of net new capital in Q3 2020, opening 363 new positions and adding to 1,147 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 93,678 shares worth $31.4M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Capital One, an estimated $35.3M trimmed.
- Cubist Systematic Strategies's largest Q3 2020 buy was State Street SPDR S&P 500 ETF Trust: 93,678 shares worth $31.4M.
- Cubist Systematic Strategies added most to Visa in Q3 2020, an estimated $38.5M increase.
- Cubist Systematic Strategies's biggest Q3 2020 reduction was Capital One, cutting an estimated $35.3M.
- Cubist Systematic Strategies fully exited Steris in Q3 2020, selling an estimated $19.6M.
- Cubist Systematic Strategies's ten largest holdings make up 4.5% of its $6.75B portfolio in Q3 2020.
- Cubist Systematic Strategies opened 363 new positions and closed 272 in Q3 2020.
- Cubist Systematic Strategies's portfolio value rose 17% quarter-over-quarter to $6.75B.
Based on Cubist Systematic Strategies's 13F filing for Q3 2020, filed 16 Nov 2020.